Literature DB >> 23077238

Protein kinase C-θ clustering at immunological synapses amplifies effector responses in NK cells.

Ernesto Merino1, Thushara P Abeyweera, Matthew A Firth, Carolyn L Zawislak, Roshni Basu, Xin Liu, Joseph C Sun, Morgan Huse.   

Abstract

In lymphocytes, stimulation of cell surface activating receptors induces the formation of protein microclusters at the plasma membrane that contain the receptor itself, along with other signaling molecules. Although these microclusters are generally thought to be crucial for promoting downstream cellular responses, evidence that specifically links clustering potential to signaling output is lacking. We found that protein kinase C-θ (PKCθ), a key signaling molecule in multiple lymphocyte subsets, formed microclusters in activated NK cells. These microclusters coalesced within the immunological synapse between the NK cell and its target cell. Clustering was mediated by the regulatory region of PKCθ and specifically required a putative phosphotyrosine-binding site within its N-terminal C2 domain. Whereas expression of wild-type PKCθ rescued the cytokine production defect displayed by PKCθ-deficient NK cells, expression of a PKCθ point-mutant incapable of forming microclusters had little to no effect. Hence, PKCθ clustering was necessary for optimal effector function. Notably, only receptors containing ITAMs induced PKCθ microclusters on their own, explaining previous observations that ITAM-coupled receptors promote stronger activating signals and effector responses than do receptors lacking these motifs. Taken together, our results provide a cell biological basis for the role of PKCθ clustering during NK cell activation, and highlight the importance of subcellular compartmentalization for lymphocyte signal transduction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23077238     DOI: 10.4049/jimmunol.1200825

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

Review 1.  Lipid-based patterning of the immunological synapse.

Authors:  Morgan Huse
Journal:  Biochem Soc Trans       Date:  2014-12       Impact factor: 5.407

Review 2.  From lipid second messengers to molecular motors: microtubule-organizing center reorientation in T cells.

Authors:  Morgan Huse; Audrey Le Floc'h; Xin Liu
Journal:  Immunol Rev       Date:  2013-11       Impact factor: 12.988

3.  IFNα signaling through PKC-θ is essential for antitumor NK cell function.

Authors:  Natalia R Comet; Juan Ignacio Aguiló; Moeez G Rathoré; Elena Catalán; Johan Garaude; Gilles Uzé; Javier Naval; Julián Pardo; Martín Villalba; Alberto Anel
Journal:  Oncoimmunology       Date:  2014-11-14       Impact factor: 8.110

Review 4.  In and out of the bull's eye: protein kinase Cs in the immunological synapse.

Authors:  Kok-Fai Kong; Amnon Altman
Journal:  Trends Immunol       Date:  2013-02-19       Impact factor: 16.687

5.  The variable hinge region of novel PKCs determines localization to distinct regions of the immunological synapse.

Authors:  Roshni Basu; Yuedan Chen; Emily J Quann; Morgan Huse
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

6.  Inhibition of SHP-1 activity by PKC-θ regulates NK cell activation threshold and cytotoxicity.

Authors:  Aviad Ben-Shmuel; Batel Sabag; Abhishek Puthenveetil; Guy Biber; Moria Levy; Tammir Jubany; Fatima Awwad; Roshan Kumar Roy; Noah Joseph; Omri Matalon; Jessica Kivelevitz; Mira Barda-Saad
Journal:  Elife       Date:  2022-03-08       Impact factor: 8.140

7.  Protein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector Functions.

Authors:  Maxi Scheiter; Björn Bulitta; Marco van Ham; Frank Klawonn; Sebastian König; Lothar Jänsch
Journal:  Front Immunol       Date:  2013-03-18       Impact factor: 7.561

8.  Inhibitory receptor signaling destabilizes immunological synapse formation in primary NK cells.

Authors:  Thushara P Abeyweera; Molly Kaissar; Morgan Huse
Journal:  Front Immunol       Date:  2013-11-27       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.